Skip to content
healthcare.dev

BLINCYTO

NDC 55513-160, blinatumomab, kit, from Amgen, Inc.

Product NDC
55513-160
Status
Listed
Labeler
Amgen, Inc
Dosage form
KIT
Route
—
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125557
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55513-160 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
55513-160-01555130160011 KIT in 1 PACKAGE (55513-160-01) * 3.088 mL in 1 VIAL (55513-150-01) * 10.6 mL in 1 VIAL (55513-155-01)
55513-160-21555130160211 KIT in 1 PACKAGE (55513-160-21) * 3.088 mL in 1 VIAL (55513-150-01) * 10.6 mL in 1 VIAL (55513-155-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/38b482a8-960b-4591-9857-5031ecb830aa
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55513-160

Use it

Look up 55513-160 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55513-160 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55513-160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.